Infectious Enteritis Treatment Market – By Drug Type (Antibiotics, Antiparasitics, Antispasmodics), Route of Administration (Oral, Injectable), Medication Type (Branded, Generics), Distribution Channel (Hospital Pharmacies) – Global Forecast (2024 – 2032)

Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Increasing incidence of foodborne disease 3.2.1.2 Growing R&D activities 3.2.1.3 Increasing awareness and education 3.2.1.4 Growing ageing population 3.2.2 Industry pitfalls & challenges 3.2.2.1 Emergence of antibiotic resistance 3.2.2.2 Complex and stringent regulatory requirements 3.3 Growth potential analysis 3.4 Regulatory landscape 3.5 Porter's analysis 3.6 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company market share analysis 4.3 Company matrix analysis 4.4 Competitive analysis of major market players 4.5 Competitive positioning matrix 4.6 Strategy outlook matrix Chapter 5 Market Estimates and Forecast, By Drug Type, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Antibiotics 5.3 Antiparasitics 5.4 Anti-spasmodics 5.5 Other drug types Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Oral 6.3 Injectable Chapter 7 Market Estimates and Forecast, By Medication Type, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Branded 7.3 Generics Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 Hospital pharmacies 8.3 Retail pharmacies 8.4 Online pharmacies Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 9.1 Key trends 9.2 North America 9.2.1 U.S. 9.2.2 Canada 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 France 9.3.4 Spain 9.3.5 Italy 9.3.6 Netherlands 9.3.7 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 South Korea 9.4.6 Rest of Asia Pacific 9.5 Latin America 9.5.1 Brazil 9.5.2 Mexico 9.5.3 Rest of Latin America 9.6 Middle East and Africa 9.6.1 Saudi Arabia 9.6.2 South Africa 9.6.3 UAE 9.6.4 Rest of Middle East and Africa Chapter 10 Company Profiles 10.1 Abbott Laboratories 10.2 Almirall SA 10.3 AstraZeneca PLC 10.4 Bristol-Myers Squibb 10.5 F. Hoffmann-La Roche Ltd 10.6 GSK plc 10.7 Medimetriks Pharmaceuticals Inc. 10.8 Merck KGaA 10.9 Pfizer Inc. 10.10 Teva Pharmaceutical Industries Ltd. 10.11 Zydus Lifesciences Ltd.